본문 바로가기 주메뉴 바로가기

Next Generation Business Model

VITALS’ goals for a Next Generation Business Model

Market Entry / Occupying / Marketing
Capacity Development Program based on R&D

CRO

Background

  • Increase in global chemical usage, Increase in domestic demand due to the enactment of K-REACH.
  • Increase in CRO demand due to the recent COVID19 outbreak and increase in globally perceived reliability of related firms.
  • Annual market growth rate of 13% (15% YoY domestically)
  • Lack of domestic organizations and company infrastructure related to chemical testing, resulting in increasing demand to expand the base for testing and evaluation

VITALS’ advantage

  • As a Inhalation Toxicity Chamber manufacturer, VITALS possesses an absolute advantage when it comes to Inhalation Toxicity and Environmental Hazardousness testing, which is a relatively weak spot for domestic CRO.
  • It can service multiple functions at once such as securing non-test data that is currently unperformable by GLP institutions, consulting for chemical substance registration, and establishing international cooperation systems for global advancement.

Medical waste

Background

  • Methods for the safe treatment of infectious medical waste and the reducing of the emissions of such materials are in urgent demand
  • Social problems caused by increasing medical waste and lack of incineration facilities need to be resolved
  • Increasing need for preventing the spread of infections due to ments of infectious medical waste
  • Demand for recycling certain wastes or converting them into general waste
  • ※ The issues are of increasing gravity due to COVID19

VITALS’ advantage

  • Possesses optimizing capabilities for processes related to grinding, sterilization, and pressurization based on the intellectual know-how of manufacturing machinery dealing with toxic substances.
  • Has laid the groundwork for establishing an international cooperation system for global advancement through cooperation with the EU (France, Germany, etc.)

Fine dust / Microplastic pollution

Background

  • Fine dust is designated as a group 1 carcinogen by the International Agency for Research on Cancer (IARC), which is under the WHO.
  • There is an increasing focus on a national scale towards reducing fine dust from factors such as domestic emissions (industry, transportation, energy generation), foreign inflow, and weather conditions.
  • Demand for the preserving national health due to high concentration fine dust / fine plastic
  • Impact of Microplastic pollution on creatures and the ecosystem (global damages worth 13 trillion won / year)

VITALS’ advantage

  • Possesses manufacturing technology for identifying the cause of fine dust
  • Possesses manufacturing technology of 3D Printer fume generators designed for fine dust / microplastic research

VITALS 3D Tracking System